Cancer Biomarker Research and Personalized Medicine
| Cancer Biomarker Research and Personalized Medicine |
| Autore | Meehan James |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (428 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
1H-NMR
Akt/mTOR AmpliSeq anastomotic leak autophagy bioinformatics biomarker biomarkers bladder tumor breast cancer cancer biomarkers cancer vaccine chemoradiotherapy chemoresistance chemotherapy circulating tumor cells clear cell renal cell carcinoma colorectal cancer comparative oncology CREB1 cytokine signalling DNA methylation drug perturbation epigenetics exosomes FOXO3 gastric cancer GBP5 glycopeptide gp130 haptoglobin head and neck cancer head and neck squamous cell carcinoma hepatocellular carcinoma HNSCC hormone-dependent carcinogenesis HPV genotyping IL13Rα2 IL6ST immune response intestinal anastomosis JAK2 LC-MS/MS lincRNA-p21 lipidomics lipoprotein lipase lipoprotein subfractions liquid biopsy liquid-based biomarkers localized prostate cancer long non-coding RNA lymph node metastasis lymphocyte-to-monocyte ratio mass spectrometry meta-analysis microRNA middle-up-down multiphasic multidetector computed tomography n/a One Health ovarian cancer p16 expression p53 peripheral blood parameters personalized medicine precision medicine predictive biomarker predictive tools prognostic factors prognostic tools prostate cancer radiomics radioresistance radiosensitivity biomarkers radiotherapy rectal cancer renal cell carcinoma saliva secretome taxane telmisartan tissue-based biomarkers translational research transurethral resection triple-negative breast cancer tumor recurrence WHO/ISUP nuclear grade |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910674370003321 |
Meehan James
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Urological Cancer 2020
| Urological Cancer 2020 |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (334 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
[68Ga]Ga-PSMA PET/CT
androgen receptor androgen response angiogenesis angiogenic growth factors anoikis antiangiogenic therapy artificial intelligence biomarker biphasic imaging bladder cancer cell proliferation chelation therapy CPT1A CXCL9 deep learning delayed imaging diagnosis differential diagnosis DONSON Downstream Neighbor of SON dual-time point imaging en-bloc resection fatty acids histopathology immunohistochemistry iron KLF5 lesion positivity rate machine learning macrophages MAP1B metastatic spread microtubule MR-guided MRgRT n/a neural network oncogenes online adaptive optical mapping oxidative stress patient-derived xenografts PD-L1 PD1 precision medicine prevention prognosis prostate cancer prostate carcinoma prostate mpMRI prostatic neoplasms/epidemiology prostatic neoplasms/mortality radiotherapy RCC renal cell cancer renal cell carcinoma renal tumors research model ROS SEER Program serine stage T1 NMIBC stereotactic ablative radiation therapy (SABR) stereotactic ablative radiotherapy stroma signature therapy transcriptome transurethral resection tumor suppressor genes tumorigenesis urothelial carcinoma vascularity whole genome sequencing α1-adrenoceptor antagonists |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557354903321 |
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||